Hemolytic Uremic Syndrome

Watchlist

(log in to enable)

Retrieved

2022-04-26

Source

Gard

Trials

—

Genes

CD46, DGKE, C3, CFB, CFH, IL6, IL1B, TNF, NQO1, ALB, IL1A, EPO, CCL2, ADAMTS13, CFI, CFHR1, THBD, CFHR3, MMACHC, PRDX1, STX1A, TRIM25, STX2, VWF, CAPG, RNR2, ST8SIA2, IL10, PCSK5, PLG

CD46, DGKE, C3, CFB, CFH, IL6, IL1B, TNF, NQO1, ALB, IL1A, EPO, CCL2, ADAMTS13, CFI, CFHR1, THBD, CFHR3, MMACHC, PRDX1, STX1A, TRIM25, STX2, VWF, CAPG, RNR2, ST8SIA2, IL10, PCSK5, PLG, SH3BP4, MTHFR, CXCR4, F3, MCHR2, CXCL12, ZFP36, TLR4, CCR2, LIPG, PLA2G7, ST11, MIR126, GRHPR, WT1, AIMP2, ACKR3, GADL1, SUMF2, A4GALT, CLEC1B, DBR1, DESI1, HPLH1, CFHR5, POLDIP2, RNF19A, IL33, GRAP2, CADM1, NT5C2, AZIN2, SLC35G1, IL24, RAB7B, NLE1, AHSA1, ABO, SAA2, TP53, FGF2, EDN1, SLC25A10, MAPK14, CRK, CPB2, CLU, CDA, CD40LG, CD22, CAT, CASP1, VPS51, C4BPA, C3AR1, APCS, ANGPT2, ANGPT1, FABP1, FHL1, TM7SF2, HLA-DRB1, TGFB1, SPARC, CX3CL1, CCL20, CCL4, AGT, SAA1, REN, MAPK1, COX1, MATK, IL18, CXCL8, IL4R, IL2RA, IFNB1, HMGB1, RN7SL263P

Drugs

—

Interested in hearing about new therapies?

Hemolytic uremic syndrome (HUS) is a disorder that usually occurs when an E. coli bacterial infection in the digestive system produces toxic substances that destroy red blood cells. Symptoms include vomiting and diarrhea, fever, lethargy, and weakness. In severe cases it can lead to kidney failure or death. While this condition is most common in children, it often has a more complicated presentation in adults. Treatment may include dialysis, corticosteroids, transfusions of packed red blood cells and plasmapheresis.

Hemolytic uremic syndrome should be distinguished from atypical hemolytic uremic syndrome (aHUS). The two conditions have different causes and different signs and symptoms.